Latest in Tapestry’s Stock Climbs
Sort by
696 items
-
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.Business - MarketWatch - October 30 -
Trump Is the Majority-Owner of a Meme Stock That’s Punishing Short-Sellers
Shares of Trump Media & Technology have skyrocketed 230 percent this month as the former president eyes a second term.Business - Inc. - October 30 -
Alphabet quiets the doubters with ‘all-around’ strength that sends stock soaring
“We believe that this ship is sailing smoothly and doing everything right,” an analyst says.Business - MarketWatch - October 30 -
Super Micro’s troubles build as auditor resigns, sending stock tumbling 33%
Super Micro filing indicates Ernst & Young flagged governance concerns back in July, which was before a short seller’s report put them on the minds of investors.Business - MarketWatch - October 30